2012 Current Cancer Dedicated to bringing the latest news and information on cancer diagnosis, treatment and prevention.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Avastin (bevacizumab) in combination with standard chemotherapy (carboplatin and paclitaxel) as a front-line (first-line following surgery) treatment for women with advanced ovarian cancer. Ovarian cancer is the most deadly of the gynaecological cancers, with approximately 220,000 women diagnosed and 140,000 women ...

Blue Shield of California will stop covering the breast cancer drug Avastin as of Oct. 17. However, it will still pay for the drug if deemed necessary on a case-by-case basis or if members are currently under treatment with the drug, reports the New York Times. The decision makes Blue Shield the largest insurer to ...

Johnson & Johnson has announced the winner of the 2011 Dr. Paul Janssen Award for Biomedical Research during the BIO International Convention (BIO) in Washington D.C. Napoleone Ferrara, M.D., is the seventh leading scientist to win the Award, which honors a scientist or team of scientists whose contributions have the potential to significantly improve the ...

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical trial led by Johns Hopkins experts, are scheduled for presentation on Saturday, June 4 at the 2011 American Society ...

Responding to the decision by NICE not to recommend Everolimus as a treatment for advanced kidney cancer, Mike Hobday, Head of Policy at Macmillan Cancer Support, said: ‘This is very disappointing news for cancer patients with advanced kidney cancer, who have repeatedly lost out on getting drugs on the NHS. Drugs for rarer cancers are ...